Genetically proxied GLP1R agonism associated with a reduced risk of heart failure (odds ratio [OR] per 1 mmol/mol decrease in glycated hemoglobin, 0.75; 95% CI, 0.64–0.87; P=1.69×10−4). This evidence concerns the gene GLP1R and heart failure.